Soluble curcumin and its derivatives

Patent metadata

Field	Value
Publication number	US-12594249-B2
Application number	US-202418732567-A
Country	US
Kind code	B2
Filing date	Jun 3, 2024
Priority date	Jun 2, 2023
Publication date	Apr 7, 2026
Grant date	Apr 7, 2026

Abstract

Disclosed is a composition including ammonia and curcumin or curcuminoid, such as an ammonium phenoxide of curcumin. Also disclosed is a method for forming an ammonium phenoxide of curcumin or curcuminoid including dissolving the curcumin or curcuminoid in an ammonia solution. Further disclosed is a method of treating a curcumin-improvable condition including administering an ammonium phenoxide of curcumin or curcuminoid to a subject.

First claim

The invention claimed is:

1 . A composition comprising an ammonium phenoxide of curcumin or a curcuminoid,
wherein the ammonium phenoxide of curcumin has the following structure:

and the curcuminoid is selected from the group consisting of: curcumin glucuronide, tetrahydrocurcumin, curcumin sulfate, hexahydrocurcuminol, demethoxycurcumin, bisdemethoxycurcumin, and cyclocurcumin, and
wherein the ammonium phenoxide of the curcumin or curcuminoid when dissolved in an aqueous solution remains dissolved in an acidic pH.

2 . The composition of claim 1 , further comprising a dissolution enhancer.

3 . The composition of claim 2 , wherein the dissolution enhancer is sodium carbonate.

4 . The composition of claim 1 , further comprising a dietary ingredient, a food additive, or a pharmaceutically acceptable additive.

5 . The composition of claim 4 , wherein the pharmaceutically acceptable additive comprises one or more of a solubilizer, an enzyme inhibiting agent, an anticoagulant, an antifoaming agent, an antioxidant, a coloring agent, a coolant, a cryoprotectant, dilutant, a hydrogen bonding agent, a flavoring agent, a flow agent, a plasticizer, a preservative, a sweetener, a thickener, and a carrier.

6 . The composition of claim 4 , wherein the pharmaceutically acceptable additive comprises one or more of calcium phosphate, cellulose, stearic acid, crosscarmellose cellulose, magnesium stearate, and silicon dioxide.

7 . The composition of claim 1 , further comprising a binder.

8 . The composition of claim 1 , wherein the composition is in the form of a capsule, a cachet, a pill, a tablet, a powder, a granule, a pellet, a bead, a particle, a troche, a lozenge, a pastille, a solution, an elixir, a syrup, a tincture, a suspension, an emulsion, a mouthwash, a spray, a drop, an ointment, a cream, a gel, a paste, a transdermal patch, a suppository, a pessary, cream, a gel, a paste, or a foam.

9 . The composition of claim 1 , further comprising a lubricant.

10 . The composition of claim 9 , wherein the lubricant comprises one or more of magnesium stearate, calcium stearate, talc, and colloidal silica.

11 . The composition of claim 1 , wherein the composition comprises 5-95% ammonium phenoxide of curcumin by weight.

12 . The composition of claim 1 further comprising human saliva, human gastric juice, human enteric juice, or any combination thereof.

13 . A method for forming the ammonium peroxide of the curcumin or curcuminoid according to claim 1 , comprising dissolving the curcumin or curcuminoid in an ammonia solution, wherein the molar ratio of ammonia to the curcumin or curcuminoid is about 1:1 to about 2:1.

14 . The method of claim 13 , further comprising drying the ammonia solution comprising the dissolved curcumin or curcuminoid to produce a dried product.

15 . The method of claim 14 , further comprising grinding the dried product to produce a powder.

16 . The method of claim 13 , wherein the ammonia solution comprises about 5 wt % to about 40 wt % ammonia.

17 . The composition of claim 1 , wherein the acidic pH is about 3.

Assignees

• Thermolife Int Llc

Inventors

• Kramer Ronald
• Nikolaidis Alexandros

Classifications

• A61P21/00 Primary

  Drugs for disorders of the muscular or neuromuscular system · CPC title

• A61P19/02

  for joint disorders, e.g. arthritis, arthrosis · CPC title

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• A61K47/02

  Inorganic compounds · CPC title

• A61K9/143

  with inorganic compounds · CPC title